Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
September 29, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
September 24, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
September 08, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
September 03, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office
September 02, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital
September 02, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
August 27, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 18, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025
August 11, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
NRXP
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.